Read this application note to learn about two expert-curated databases for cancer drug discovery, the Catalogue of Somatic Mutations in Cancer (COSMIC) and the Human Somatic Mutation Database (HSMD), enable biopharmaceutical researchers to avoid pitfalls in early cancer drug discovery, confidently qualify candidate drug targets, and accelerate indication expansion and repurposing of existing cancer therapies.
Key topics covered:
We'd love to show you how QIAGEN's expert-curated databases can help your cancer drug discovery program improve target identification and validation, optimize clinical trial design, and accelerate drug repurposing.
Click the button below to connect with a dedicated expert who can give you a demonstration customized to your goals and needs.
